Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrew Levy

Orthopaedic Surgery Millburn, NJ Medical Doctor

NPI 1386712032 CMS profile 62357

89 Millburn Ave Ste 102, Millburn, NJ 07041

Open in the dashboard

General payments

$363,633

241 records reported · program years 2019–2025

Research payments

$18,000

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$227,966

1 holding reported · through program year 2025

Research they led as principal investigator

$1,700 paid to institutions, not to them · program years 2021–2022

Through program year 2025, Andrew Levy of Millburn, NJ is reported in the CMS Open Payments database as having received $363,633 across 241 general payments and $18,000 in research payments paid to them. Separately, studies naming them as principal investigator received $1,700 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $227,966 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $45,098 56
2024 General $267,024 56
2024 Research $5,175 1
2023 General $6,715 7
2023 Research $4,950 1
2022 General $17,241 28
2021 General $3,638 25
2021 Research $7,875 1
2020 General $8,437 26
2019 General $15,480 43
2023 Ownership $227,966 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Levy
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Andrew Levy were reported at $45,098. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Andrew Levy Orthopaedic Surgery median Middle half National median
2019 $15,480 $644 $140–$2,844 $163
2020 $8,437 $312 $75–$1,860 $114
2021 $3,638 $520 $117–$2,495 $132
2022 $17,241 $598 $128–$2,731 $149
2023 $6,715 $461 $128–$2,264 $160
2024 $267,024 $497 $134–$2,475 $164
2025 $45,098 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $313,028 141 payments
  2. Bioventus LLC $27,684 40 payments
  3. Zimmer Biomet Holdings, Inc. $19,220 17 payments
  4. Stryker Corporation $1,304 10 payments
  5. Encore Medical, LP $743 10 payments
  6. Biorez, Inc. $500 1 payment
  7. Joint Restoration Foundation, Inc. $289 1 payment
  8. Anika Therapeutics, Inc. $235 3 payments
  9. BIOTRONIK NRO, Inc. $126 1 payment
  10. Amniox Medical, Inc. $100 1 payment
  11. Other $404 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Acquisitions $227,966 1 payment
  2. Consulting Fee $65,335 44 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $29,900 11 payments
  4. Education $17,777 8 payments
  5. Travel and Lodging $15,639 62 payments
  6. Food and Beverage $7,016 115 payments
Products named General payments · program years 2019–2025
  1. AccuFill $10,113 5 payments
  2. Arcos $5,300 2 payments
  3. Persona $2,507 3 payments
  4. Other $1,389 11 payments
  5. Oxford $1,300 7 payments
  6. Regeneten $943 8 payments
  7. ICONIX $869 6 payments
  8. ACUFEX Meniscal Root Repair $582 2 payments
  9. BioBrace 23mm $500 1 payment
  10. BioBrace 5mm $500 1 payment
  11. Other $7,446 130 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Aesculap Biologics, LLC $18,000 3 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

21

Median for Orthopedic Surgery: 203

Drug cost

$100

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 21 $100

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 12 billing codes

Paid by Medicare

$5,571

Medicare's payments for the services billed

Medicare patients

20

Average age 75

Services billed

161

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

244 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record